Previous 10 | Next 10 |
Redbox Entertainment (RDBX) -21%. Hillstream BioPharma (HILS) -13%. DBV Technologies (DBVT) -11%. Day One Biopharmaceuticals (DAWN) -8% on $125M share offering. AeroClean Technologies (AERC) -8%. MicroStrategy (MSTR) -7% Bitcoin and ether deepen their slump, pulling MicroS...
Penny stocks are well-known for their quick gain potential. Not only do cheap prices lend themselves to swift percentage gains, but these low-priced stocks generally represent shares of smaller companies. In many cases, there are fewer total shares outstanding, fewer shares available in pub...
Hillstream BioPharma (NASDAQ:HILS) share are surging up 55% premarket on a share repurchase program to acquire up to $1M of the company's common stock. The company had ~$11.1M in cash and 11.4M shares of common stock outstanding as of March 31, 2022. “We have demon...
BRIDGEWATER, N.J., June 13, 2022 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream”, the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in...
Recent milestones include FDA Orphan Drug Designations for HSB-1216 and HSB-888 World-class scientific advisory team and growing and distinguished patent portfolio remain key competitive advantages Company ended Q1 2022 with $11 million in cash Provides roadmap o...
Developed in partnership with J.P. Morgan and Johnson & Johnson Innovation, the Conference will bring together more than 500 life sciences professionals and thought leaders Hillstream’s presentation will feature its flagship treatment, HSB-1216, which targets solid ...
HSB-1216 ’s active moiety in clinical pilot study produced a 71% response rate in TNBC and epithelial carcinomas HSB-1216 was recently granted O rphan Drug Designation to treat Uveal Melanoma by the FDA Rare ...
Vancouver, Kelowna, Delta, BC - February 25, 2022 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces its weekly roundup of stocks to watch in Biotech, Cannabis and Mining. Today's stocks have been added to our lists of free sto...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Febr...
Hillstream BioPharma (NASDAQ:HILS) spiked before paring gains in the morning hours on Wednesday after the company announced that the U.S. Food and Drug Administration (FDA) granted the Orphan Drug Designation to HSB-1216 for Uveal Melanoma (UM). A type of cancer involving the human eye, Uveal...
News, Short Squeeze, Breakout and More Instantly...
Hillstream BioPharma Inc. Company Name:
HILS Stock Symbol:
NASDAQ Market:
Expects to launch and complete a Phase 1 trial in Q4 2023 Tharimmune to begin trading under new ticker, THAR, on Monday September 25, 2023 BRIDGEWATER, NJ / ACCESSWIRE / September 22, 2023 / Hillstream BioPharma Inc., (NASDAQ:HILS), a biotechnology company developing innovative therapeu...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic prur...